导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 86.92% | 6/1050 |
| 近一周 | 2.82% | 7/1104 |
| 近一月 | -4.58% | 562/1102 |
| 近一季 | -20.46% | 989/1092 |
| 近半年 | 80.59% | 2/1070 |
| 近一年 | 113.59% | 4/1018 |
| 近两年 | 453.69% | 2/926 |
| 近三年 | 400.68% | 2/834 |
| 成立以来 | 298.67% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
6.85% 90/1070 |
134.42% 2/1101 |
- - |
- - |
| 2025 | 99.86% 9/1065 |
-13.98% 1002/1014 |
8.93% 134/1038 |
86.12% 2/1050 |
14.60% 25/1065 |
| 2024 | 31.33% 18/1011 |
3.31% 153/960 |
4.94% 96/983 |
1.20% 949/991 |
19.70% 19/1011 |
| 2023 | -7.97% 274/952 |
8.72% 155/880 |
-0.43% 213/895 |
-16.02% 800/915 |
1.23% 87/952 |
| 2022 | -26.24% 536/867 |
-19.48% 491/773 |
2.72% 639/806 |
-1.10% 26/845 |
-9.83% 782/867 |
| 2021 | 10.53% 241/740 |
-0.37% 165/580 |
14.83% 239/659 |
-7.03% 414/704 |
3.91% 264/740 |
| 2020 | 41.92% 291/554 |
1.01% 135/419 |
29.88% 132/466 |
2.86% 390/517 |
5.17% 436/554 |
| 2019 | 33.61% 272/410 |
3.18% 1075/1146 |
-4.70% 686/1228 |
27.36% 4/390 |
6.68% 287/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 财通集成电路产业股票C VS. 东吴新产业精选股票A(580008) |